---

---

tags : Fda    crawled date : 2021 - 11 - 01   

save search

---

Janssen Announces Extension of U.S. FDA BLA PDUFA Date for BCMA CAR-T Ciltacabtagene Autoleucel
Published: 2021-11-01 (Crawled : 21:00) - prnewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M |

Health Technology

| -11.22% | O: 0.26% H: 2.0% C: 1.15%
fda pdufa car-t

---

Cocrystal Pharma Submits Pre-Investigational New Drug Briefing Package to the FDA for Clinical Development Guidance of CDI-45205 for COVID-19 Treatment
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
COCP | $1.495 4.55% -1.39% 5.1K |

Health Technology

| 68.12% | O: 3.12% H: 3.26% C: 2.72%
covid new drug treatment fda drug

---

Theseus Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for THE-630, a Pan-Variant KIT Inhibitor in Development for the Treatment of Gastrointestinal Stromal Tumors (GIST)
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
THRX | $4.06 0.49% 0 |

| -76.26% | O: 1.05% H: 2.6% C: -0.98%
new drug fda clearance treatment fda application test gastrointestinal drug clearance

---

Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM2 Gene Therapy in Patients with GM2 Gangliosidosis
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
SIOX | $0.478 -20.5% 40K |

Health Technology

| -75.39% | O: 0.0% H: 6.28% C: 6.28%
fda fda fast track gene therapies fast track gene therapy therapy fast track designation designation

---

COVID-19 Update: FDA Vaccine Approval, Booster Shots, and Trying to Conceive
Published: 2021-11-01 (Crawled : 18:00) - progyny.com
PGNY | $31.88 -2.66% -2.73% 1M |

Commercial Services

| -46.69% | O: 0.28% H: 2.64% C: 0.65%
covid fda vaccine approval covid-19

---

FDA approves Novartis Scemblix® (asciminib), with novel mechanism of action for the treatment of chronic myeloid leukemia
Published: 2021-11-01 (Crawled : 15:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 11.47% | O: -0.42% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K |

Health Technology

| 12.47% | O: 1.3% H: 0.0% C: 0.0%
treatment fda myeloid leukemia leukemia fda approval

---

Koning Begins FDA Clinical Screening Trial in Daytona Beach, Florida
Published: 2021-11-01 (Crawled : 15:00) - prnewswire.com
FNCTF | News | $11.0354 -0.83% -20.84% 0 |

Communications

| Email alert Add to watchlist
fda trial

---

Lexaria Announces R&D Program to Compare First and Only FDA-Approved Prescription Cannabidiol
Published: 2021-11-01 (Crawled : 14:00) - biospace.com/
LEXX | $2.25 -3.85% -4.0% 120K |

Health Technology

| -62.2% | O: 4.52% H: 0.25% C: -2.16%
fda fda approval

---

COVID-19 Update Webinar: FDA Vaccine Approval, Booster Shots, and Trying to Conceive
Published: 2021-11-01 (Crawled : 13:00) - progyny.com
PGNY | $31.88 -2.66% -2.73% 1M |

Commercial Services

| -46.69% | O: 0.28% H: 2.64% C: 0.65%
covid fda vaccine approval covid-19

---

Coherus and Junshi Biosciences Announce FDA Acceptance of BLA Filing for Toripalimab for Treatment of Nasopharyngeal Carcinoma
Published: 2021-11-01 (Crawled : 12:15) - biospace.com/
ABBV | News | $164.66 0.25% -0.14% 3.6M |

Health Technology

| 47.2% | O: 2.72% H: 0.41% C: -0.38%
CHRS | $2.0 -6.98% -8.04% 1.8M |

Health Technology

| -87.15% | O: 1.49% H: 3.83% C: 0.0%
treatment fda fda acceptance

---

Junshi Biosciences and Coherus Announce FDA Acceptance of BLA Filing for Toripalimab for Treatment of Nasopharyngeal CarcinomaFDA has granted the toripalimab BLA Priority Review with a target action date of April 2022
Published: 2021-11-01 (Crawled : 12:15) - biospace.com/
ABBV | News | $164.66 0.25% -0.14% 3.6M |

Health Technology

| 47.2% | O: 2.72% H: 0.41% C: -0.38%
CHRS | $2.0 -6.98% -8.04% 1.8M |

Health Technology

| -87.15% | O: 1.49% H: 3.83% C: 0.0%
treatment fda fda acceptance granted

---

ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin™ Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome
Published: 2021-11-01 (Crawled : 12:00) - biospace.com/
ANIP | News S | $64.58 -1.37% -1.36% 180K |

Health Technology

| 69.98% | O: 9.77% H: 41.84% C: 31.63%
multiple sclerosis fda rheumatoid arthritis fda approval sclerosis approval syndros

---

Gainers vs Losers

60%

40%

Top 10 Gainers

AGBA | News | $1.03 157.5% 57.94% 120M |

Finance

ZCMD | $1.45 5.84% 52.1% 2.3M |

Commercial Services

INVO | $1.52 100.0% 51.13% 5M |

Health Technology

ISPC | $0.421 97.65% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.5 45.65% 470K |

OST | $0.509 23.81% 45.26% 90K |

GDHG | $0.263 21.76% 40.66% 3.1M |

XPON | News | $3.15 63.21% 37.74% 16M |

TIRX | $0.8 65.02% 30.74% 58M |

BNTC | News | $6.82 42.08% 30.64% 3.5M |

Health Technology

---

Your saved searches

---